CMCarlo Monsanto

Carlo Monsanto

*This is an algorithmically generated author record based on publicly available information.

Carlo Monsanto has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Embodying Flow: Living Through The Mind-Body Continuum

    by Carlo Monsanto

    Quantum social learning (QSL) is an emerging action learning approach that has been inspired by various disciplines, and specially the work of David Bohm in “rheomode” or “flow mode.” QSL uses a novel psychosocial interpretation of quantum theory to describe the central role that awareness and the heart play in synchronizing the body's systems and their activity at all scales and contexts, including how we interact socially. QSL describes awareness as a ground state, like a black hole, with a quantum potential to unfold and fold back (enfold) conscious experience. The heart acts as the seed and center of our human galaxy, attracting, shaping, and evolving the surrounding cells into tissues, organs, and other systems. We also describe how disappointments, adverse childhood experiences, and trauma keep experiences from completing and folding back and repress and suppress the same toward the unconscious background. Combining grounding and decoding processes HEAL enables us to hold space for the unresolved past experiences to be received, transformed and fold back into awareness. At the same time, cathartic transformations expand us beyond our limiting beliefs, habit patterns, and perceptions, rendering clarity and heightened awareness and presence.

  • Open Access

    Viroinformatics-Based Analysis of SARS-CoV-2 Core Proteins for Potential Therapeutic Targets

    by Lokesh Agrawal, Thanasis Poullikkas, Scott Eisenhower, Carlo Monsanto, Ranjith Kumar Bakku, Min-Hua Chen, Rajkumar Singh Kalra

    SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a novel coronavirus for which no known effective antiviral drugs are available. In the present study, to accelerate the discovery of potential drug candidates, bioinformatics-based in silico drug discovery approaches are utilized. We performed multiple sequence alignments of the Spike (S) protein with 75 sequences of different viruses from the Orthocoronavirinae subfamily. This provided us with insights into the evolutionarily conserved domains that can be targeted using drugs or specific antibodies. Further, we analyzed the mechanism of SARS-CoV-2 core proteins, i.e., S and RdRp (RNA-dependent RNA polymerase), to elucidate how the virus infection can utilize hemoglobin to decrease the blood oxygen level. Moreover, after a comprehensive literature survey, more than 60 antiviral drugs were chosen. The candidate drugs were then ranked based on their potential to interact with the Spike and RdRp proteins of SARS-CoV-2. The present multidimensional study further advances our understanding of the novel viral molecular targets and potential of computational approaches for therapeutic assessments. The present study can be a steppingstone in the selection of potential drug candidates to be used either as a treatment or as a reference point when designing a new drug/antibody/inhibitory peptide/vaccine against SARS-CoV-2.